BTG plc (BTG) Earns Neutral Rating from J P Morgan Chase & Co

J P Morgan Chase & Co reaffirmed their neutral rating on shares of BTG plc (LON:BTG) in a report released on Monday.

A number of other equities analysts also recently commented on BTG. Panmure Gordon reduced their price objective on shares of BTG plc from GBX 809 ($10.91) to GBX 793 ($10.69) and set a buy rating for the company in a report on Monday, May 22nd. Numis Securities Ltd reaffirmed a buy rating and set a GBX 900 ($12.13) price objective on shares of BTG plc in a report on Monday, May 22nd. Shore Capital reaffirmed a not rated rating on shares of BTG plc in a report on Thursday, July 13th. Finally, Stifel Nicolaus reaffirmed a buy rating and set a GBX 800 ($10.79) price objective on shares of BTG plc in a report on Wednesday, August 30th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of Buy and a consensus target price of GBX 780.33 ($10.52).

Shares of BTG plc (LON BTG) opened at 664.50 on Monday. The firm’s market cap is GBX 2.56 billion. BTG plc has a 1-year low of GBX 528.36 and a 1-year high of GBX 738.50. The company’s 50-day moving average is GBX 672.19 and its 200 day moving average is GBX 655.00.

TRADEMARK VIOLATION WARNING: This report was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/09/21/btg-plc-btg-earns-neutral-rating-from-j-p-morgan-chase-co.html.

About BTG plc

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Analyst Recommendations for BTG plc (LON:BTG)

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply